Statement: Emily has an Inoperable non-metastatic breast cancer, she is eligible for both the secondary trial and the primary trial.
Primary_evidence: Inclusion Criteria:   Operable breast cancer Exclusion Criteria:   Inoperable breast cancer   BMI > 25   Neoadiuvant radioterapy   Carcinomastitis   Previous phlebitis of omolateral arm Collagen disease
Secondary_evidence: Inclusion Criteria:   Written informed consent of the patient signed by herself.   Histologically confirmed metastatic or recurrent adenocarcinoma of the breast.   Aged 20 to 74 at the time of informed consent. Exclusion Criteria:   Prior systemic chemotherapy with taxane anticancer drugs for metastatic or recurrent breast cancer.